Oxybutynin Extended-Release Tablets and Zoladex (Goserelin Implant 3.6 mg)
Determining the interaction of Oxybutynin Extended-Release Tablets and Zoladex (Goserelin Implant 3.6 mg) and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: oxybutynin
Brand name: Ditropan XL, Anturol, Gelnique, Oxytrol
Synonyms: Oxybutynin
Generic Name: goserelin
Brand name: Zoladex
Synonyms: Zoladex
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Oxybutynin Extended-Release Tablets-Zoladex 3-Month
- Oxybutynin Extended-Release Tablets-Zoladex Implant
- Oxybutynin Extended-Release Tablets-Zolate
- Oxybutynin Extended-Release Tablets-Zoledronic acid
- Oxybutynin Extended-Release Tablets-Zoledronic Acid (Bone Health)
- Oxybutynin Extended-Release Tablets-Zoledronic Acid (Zometa)
- Zoladex (Goserelin Implant 3.6 mg)-Oxybutynin Gel
- Zoladex (Goserelin Implant 3.6 mg)-Oxybutynin Oral Solution
- Zoladex (Goserelin Implant 3.6 mg)-Oxybutynin Syrup
- Zoladex (Goserelin Implant 3.6 mg)-Oxybutynin Tablets
- Zoladex (Goserelin Implant 3.6 mg)-Oxybutynin transdermal
- Zoladex (Goserelin Implant 3.6 mg)-Oxybutynin Transdermal System